Select Medical (SEM) Q1 2026 Earnings Report Highlights Take-Private Transaction and Financial Performance
Select Medical (SEM) reported Q1 2026 earnings with a 5% revenue increase, though adjusted EBITDA declined 6.5% to $141 million. The company announced a take-private transaction offering $16.50 per share to unaffiliated shareholders, contingent on regulatory approval. Inpatient rehabilitation revenue rose 14% with improved occupancy and margin.
Tickers: $SEM
Topics: dividend earnings EBITDA regulatory updates revenue take-private transaction